The effect of excitability changes may be either homeostatic, counteracting synaptic changes (Zhang and Linden, 2003
[68] I first learned about this connection in my early days as a consulting pharmacist, working with people with developmental disabilities who had used various medications for epilepsy
IGF-I ELISA AL-121
Our review provides insights into the interplay of lifestyle factors, genetic predispositions, and the significant psychological and physiological burdens associated with managing these comorbid conditions
The FDA usually follows its advisory committees, but it isnt required to
Image courtesy of: Michael Feely, DO, University of Florida, Gainesville, Florida, USA